TrakCel Ltd. Adds Cognate BioSevices to Connected Services Program
TrakCel Ltd., a cell therapy process management and supply chain integration technology, recently introduced Cognate BioServices as the newest member of its Connected Service program, according to a Nov. 10, 2015 press release.
Cognate Bioservices is a fully integrated contract bioservices organization providing development and cGMP-manufacturing services to institutions engaged in the development of cell-based products.
The Connected Services partner ecosystem accelerates cell therapy success by enhancing TrakCel's cell therapy supply chain management platform, according to TrakCel. This improvement to the platform supports therapy success by providing links to participant firms specializing in logistics, cell therapy manufacturing, patient treatment, storage, and compliance.
TrakCel’s technology provides additional transparency into the entire cell therapy process, while providing real-time audit logs and chain-of-custody records of critical components.
Source: TrakCel
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
